Navigation Links
Advances in Science and Treatment of Pain Presented at 25th Annual American Academy of Pain Medicine Meeting January 28 - 31, 2009
Date:1/26/2009

Further Understanding of Pain as a Disease Leads to Innovation in Treatment

GLENVIEW, Ill., Jan. 26 /PRNewswire/ -- The American Academy of Pain Medicine's (AAPM) 2009 Annual Meeting - its 25th Anniversary - will take place in Hawaii this week with over 200 scientific posters, presentations and sessions. More than 750 physicians and other healthcare providers who research pain, or treat patients with pain, will attend.

"Over the last 25 years there has been an unprecedented evolution of pain medicine, science, and practice. Our scientists are discovering the mechanisms that cause injuries and diseases which damage the spinal cord and brain so that in many cases chronic pain becomes a progressive disease, not just a symptom," said incoming AAPM President and Editor-in-Chief of Pain Medicine, Rollin M. Gallagher, MD MPH. "We have also seen an exponential increase in interventions for back pain, migraines, and traumatic injury patients. And there has been incredible progress in developing several different classes of medicines that work at many levels of the body, spinal cord, and brain to effectively treat pain, including medications with decreased abuse potential."

At this year's meeting, attendees will have access to latest research on the most innovative treatments in a multitude of therapeutic areas, as well as attend sessions to learn more about war and pain, and about advancements in pain management in Pacific Rim countries such as Australia and China.

"With the progress made in global pain medicine research and care, it is the perfect time to converge all approaches to help achieve the best outcomes for patients," Gallagher concluded.

All presentations at AAPM's 25th Annual Meeting are embargoed until the time and date of presentation. All times listed are Hawaii-Aleutian Standard Time (HAST). Following are highlighted plenary sessions and posters:

    Thursday, January 29, 2009 7:00 AM -8:00 AM HAST
    Coral Ballroom, Hilton Hawaiian Village
    Neuroplasticity and Chronic Pain, Norman Doidge, MD PhD Dsc

    Friday, January 30, 2009 10:00 AM - 11:00 AM HAST
    Coral Ballroom, Hilton Hawaiian Village
    Acupuncture: Historical Perspectives and Emerging Advances
     in Treatment of Pain and Addiction, Jisheng Han, MD

    Saturday, January 31, 2009 10:15 AM - 11:15 AM HAST
    Coral Ballroom, Hilton Hawaiian Village
    WAR and PAIN: From Battlefield to Back Home
    Chester 'Trip' Buckenmaier, III, MD COL MC and R. Norman Harden, MD

    Wednesday, January 28, 2009 3:30 PM - Thursday, January 29, 2009,
     10:00 AM HAST
    Coral Ballroom Foyer, Hilton Hawaiian Village
    Authors present Jan. 28 from 5-6:30 PM and Jan. 29 from 9-10 AM

    Spinal Cord Stimulation for Chronic Pain, Poster 117
    Spinal Cord Stimulation for Chronic Pain Review, Poster 121
    Peripheral Nerve Stimulation Outcomes, Poster 126
    Artery of Adamkiewcz and Interventional Pain Management, Poster 135
    Sinergy Treatment for Sacroiliac Joint Pain, Poster 139
    Variations in Epidural Steroid Injections, Poster 142
    Interventional Treatment for Chronic Migraine, Poster 146
    Pain Management in Pediatric Cancer Patients, Poster 153
    Interventional Treatment for Intractable Migraine, Poster 155
    Acute Treatment of Intractable Migraine, Poster 157
    Chronic Pain and Depression, Poster 175
    GABAergic Interneurons and Chronic Post-Ischemic Pain, Poster 178

    Thursday, January 29, 2009 3:30 PM - Friday, January 30, 2009,
     10:00 AM HAST
    Coral Ballroom Foyer, Hilton Hawaiian Village
    Authors present Jan. 29 from 3:30-5 PM and Jan. 30 from 9-10 AM

    Calcium Channel Blockers Compared for Neuropathic Pain, Poster 181
    Addictive Qualities of Cannabinoid Medication, Poster 193
    Tramadol Outcomes, Poster 197
    Safety, Tolerability and Effectiveness of Duloxetine for
     Fibromyalgia, Poster 204
    Effects of Oral Oxycodone in Recreational Drug Users, Poster 211
    Evaluation of High Dose Opioids in Chronic Pain Patients, Poster 220
    Long Term Opioid Therapy May Suppress Adrenal Corticosteroids, Poster 221
    Catastrophizing About Pain & Enhanced Pro-Inflammatory Pain
     Response Poster 250
    Pain Surveys of Casualties from the Iraq and Afghanistan Wars,
     Posters 252 and 253
    Outcomes of a Community-Based Pain Management Program, Poster 261
    Public Opinion Survey Regarding Prescription Pain Medication, Poster 266
    Prevalence of Chronic Pain, Poster 272
    Headaches in Iraq/Afghanistan Veterans & Trauma/Combat Injury, Poster 273
    Reduction of Opioid/Illicit Drug Abuse & Electronic
     Prescription Monitoring, Poster 274

About the AAPM

For over 25 years, the American Academy of Pain Medicine (AAPM) has been the medical specialty society representing more than 2,200 physicians practicing in the field of pain medicine. The Academy is involved in education, training, advocacy and research in the specialty of pain medicine. Information is available on the practice of pain medicine at www.painmed.org.


'/>"/>
SOURCE American Academy of Pain Medicine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
4. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
5. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
6. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
7. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
8. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
9. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
10. CuraGen Advances CR011-vcMMAE into Phase II
11. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Tenn. , March 23, 2017  Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... announced Definitive Financing Commitment Term Sheet (the "Definitive ... a group of the Company,s stockholders, who are ... Group" in a Form 8-K filed with the ...
(Date:3/24/2017)... , Mar 24, 2017 The Board ... the company,s Annual Report 2016 including the complete 2016 Annual ... and available on Nordic Nanovector,s website in the section Investor ... ... IR enquiries: Tone Kvåle, Chief Financial Officer Cell: +47-91-51-95-76 Email: ...
(Date:3/23/2017)... , March 23, 2017 Mosaic Life Care, based in ... patient registration process across its network of 58 clinics, located in 22 cities, and ... new and innovative ways to improve the delivery of health care to its patients, ... Reading ... Mosaic Life Care St. Joseph Medical Center ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... 24, 2017 , ... The Radiology Business Management Association (RBMA) has ... now in their 12th year, are among the most prestigious in radiology marketing because ... awards were retooled to recognize achievements in both large budget (over $5,000) and small ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... financial planning, and related services to families and business owners across eastern Michigan, ... at feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH Food ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ... prep patients for colonoscopy at the HyGIeaCare® Center that is to be located ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: a dauntless and ... “End Time GPS” is the creation of published author, Wesley Gerboth, a World ... military munitions and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God ...
Breaking Medicine News(10 mins):